BIOMAT Database Logo BIOMAT Database Logo

Serum calcium concentrations during treatment with isotretinoin. 1986

W E Duncan, and M Guill, and J Aton

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D015474 Isotretinoin A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. 13-cis-Retinoic Acid,Accutane,Isotretinoin Zinc Salt, 13-cis-Isomer,Ro 4-3780,Roaccutane,13 cis Retinoic Acid,Isotretinoin Zinc Salt, 13 cis Isomer,Ro 4 3780,Ro 43780

Related Publications

W E Duncan, and M Guill, and J Aton
Psychosis during treatment with isotretinoin.
August 2013, Therapeutic advances in psychopharmacology,
W E Duncan, and M Guill, and J Aton
Amenorrhoea during treatment with isotretinoin.
June 1988, The British journal of dermatology,
W E Duncan, and M Guill, and J Aton
Serum gold concentrations during treatment with auranofin.
March 1987, Clinical rheumatology,
W E Duncan, and M Guill, and J Aton
[Tietze's syndrome during treatment with isotretinoin].
January 1986, Annales de dermatologie et de venereologie,
W E Duncan, and M Guill, and J Aton
Spontaneous bruising during treatment with isotretinoin.
April 1993, The British journal of dermatology,
W E Duncan, and M Guill, and J Aton
Serum-digoxin concentrations during treatment with different preparations.
October 1971, Lancet (London, England),
W E Duncan, and M Guill, and J Aton
A comparison of serum ionized calcium concentrations and serum total calcium concentrations in dogs with lymphoma.
June 1997, Zentralblatt fur Veterinarmedizin. Reihe A,
W E Duncan, and M Guill, and J Aton
[Acute arthritis during isotretinoin treatment].
January 1994, Annales de dermatologie et de venereologie,
W E Duncan, and M Guill, and J Aton
[Muscular damage during isotretinoin treatment].
February 1998, Annales de dermatologie et de venereologie,
W E Duncan, and M Guill, and J Aton
Nummular eczema during isotretinoin treatment.
March 1987, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!